| Literature DB >> 31170913 |
Stafford Vigors1, John V O'Doherty2, Kenneth Bryan2, Torres Sweeney3.
Abstract
BACKGROUND: The improvement of feed efficiency is a key economic goal within the pig production industry. The objective of this study was to examine transcriptomic differences in both the liver and muscle of pigs divergent for feed efficiency, thus improving our understanding of the molecular mechanisms influencing feed efficiency and enabling the identification of candidate biomarkers. Residual feed intake (RFI) was calculated for two populations of pigs from two different farms of origin/genotype. The 6 most efficient (LRFI) and 6 least efficient (HRFI) animals from each population were selected for further analysis of Longissimus Dorsi muscle (n = 22) and liver (n = 23). Transcriptomic data were generated from liver and muscle collected post-slaughter.Entities:
Keywords: Feed efficiency; Multi-tissue analysis; Pig; RNA-Seq; Residual feed intake; Transcriptome
Mesh:
Year: 2019 PMID: 31170913 PMCID: PMC6555042 DOI: 10.1186/s12864-019-5740-z
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Characterisation of performance, body composition, intake and efficiency (Least square means and SEM)
| Trait | Low | Highb | SEM | |
|---|---|---|---|---|
| Farm A | 27 | 18c | ||
| RFI | −0.14 | 0.19 | 0.08 | 0.001 |
| ADFIa | 2.00 | 2.34 | 0.04 | 0.001 |
| MBW | 32.71 | 32.05 | 0.63 | 0.956 |
| ADG | 0.99 | 0.99 | 0.02 | 0.874 |
| FCR | 2.03 | 2.36 | 0.02 | 0.001 |
| BW | 76.62 | 77.70 | 1.36 | 0.833 |
| Farm B | 28 | 35 | ||
| RFI | −0.18 | 0.20 | 0.016 | 0.001 |
| ADFIa | 1.87 | 2.34 | 0.05 | 0.0001 |
| MBW | 10.94 | 11.20 | 0.19 | 0.3662 |
| ADG | 0.950 | 1.01 | 0.031 | 0.2112 |
| BW | 90.45 | 96.08 | 2.378 | 0.1086 |
a ADFI Average daily feed intake, MBW Mid-test metabolic body weight, ADG Average daily gain, RFI Residual feed intake, BW Body weight
b High = RFI was > 0.5 SD above the mean; medium = RFI was ± 0.5 SD above and below the mean; low = RFI was < −0.5 SD below the mean
c Number of animals in each RFI group
Fig. 1Hierarchical clustering based on transcriptomic differences between the HRFI and LRFI pigs in muscle. The animals grouped by RFI status and not by farm of origin (Farm A and Farm B) in both tissues. The samples were clustered based on Ward method using 1 minus spearman correlation as distance
Fig. 2Hierarchical clustering based on transcriptomic differences between the HRFI and LRFI pigs in liver. The animals grouped by RFI status and not by farm of origin (Farm A and Farm B) in both tissues. The samples were clustered based on Ward method using 1 minus spearman correlation as distance
Numbers of differentially expressed genes in LRFI compared to HRFI pigs in both Muscle and Liver
| Musclea | Livera | |||
|---|---|---|---|---|
| Total DEb genes | 6463 | 964 | ||
| Up regulated | Down regulated | Up regulated | Down regulated | |
| Total genes | 3138 | 3325 | 467 | 496 |
| FCc | 1722 | 2465 | 365 | 384 |
| FC > 1.0 | 1381 | 851 | 77 | 100 |
| FC | 35 | 10 | 25 | 12 |
a LRFI vs. HRFI
b Differentially expressed
c Fold change ratio
Fig. 3Genes that are differentially expressed between HRFI and LRFI pigs in the muscle (green are up regulated and red are down regulated). Volcano plots illustrate the magnitude and significance of differentially expressed genes between RFI groups
Fig. 4Genes that are differentially expressed between HRFI and LRFI pigs in the liver (green are up regulated and red are down regulated). Volcano plots illustrate the magnitude and significance of differentially expressed genes between RFI groups
Gene ontology terms overrepresented among differentially expressed genes in liver and muscle
| Term | Count | B-H | |
|---|---|---|---|
| GO terms overrepresented among DEGs with lower expression in the LRFI group vs HRFI group | |||
| GO:0006612~protein targeting to membrane | 10 | 2.59E-02 |
|
| GO:0030198~extracellular matrix organization | 12 | 5.45E-02 |
|
| GO terms overrepresented among DEGs with higher expression in the LRFI group vs HRFI group | |||
| GO:0006952~defense response | 32 | 9.10E-04 |
|
| GO:0009607~response to biotic stimulus | 23 | 1.21E-03 |
|
| GO:0044764~multi-organism cellular process | 24 | 1.42E-03 |
|
| GO:0034097~response to cytokine | 20 | 6.75E-03 |
|
Gene ontology terms overrepresented among differentially expressed genes in muscle
| Term | Count | B-H |
|---|---|---|
| GO terms overrepresented among DEGs with higher expression in the LRFI group vs HRFI | ||
| GO:0006464~cellular protein modification process | 765 | 1.75E-16 |
| GO:0016070~RNA metabolic process | 882 | 1.05E-12 |
| GO:0010467~gene expression | 987 | 1.05E-12 |
| GO:0007049~cell cycle | 371 | 4.46E-12 |
| GO:0051171~regulation of nitrogen compound metabolic process | 831 | 2.62E-11 |
| GO:0034645~cellular macromolecule biosynthetic process | 921 | 2.43E-10 |
| GO:0006351~transcription, DNA-templated | 684 | 2.94E-09 |
| GO:0070647~protein modification by small protein conjugation or removal | 235 | 2.69E-08 |
| GO:0051276~chromosome organisation | 256 | 5.62E-07 |
| GO:0006396~RNA processing | 206 | 5.83E-07 |
| GO terms overrepresented among DEGs with lower expression in the LRFI group vs HRFI | ||
| GO:0007005~mitochondrion organization | 204 | 1.31E-21 |
| GO:0045184~establishment of protein localisation | 445 | 1.64E-14 |
| GO:0043603~cellular amide metabolic process | 241 | 3.11E-11 |
| GO:1901566~organonitrogen compound biosynthetic process | 311 | 5.75E-11 |
| GO:0033036~macromolecule localisation | 562 | 1.57E-10 |
| GO:0051641~cellular localisation | 514 | 2.00E-10 |
| GO:0006412~translation | 167 | 5.88E-10 |
| GO:0006091~generation of precursor metabolites and energy | 112 | 1.15E-09 |
| GO:0009199~ribonucleoside triphosphate metabolic process | 87 | 4.70E-09 |
| GO:0055114~oxidation-reduction process | 228 | 8.67E-09 |
Gene ontology terms overrepresented among differentially expressed genes in liver
| Term | Count | B-H |
|---|---|---|
| GO terms overrepresented among DEGs with higher expression in the LRFI group vs HRFI group | ||
| GO:0022613~ribonucleoprotein complex biogenesis | 35 | 2.25E-04 |
| GO:0006396~RNA processing | 53 | 2.29E-04 |
| GO:0051607~defense response to virus | 22 | 5.93E-04 |
| GO:0060337~type I interferon signalling pathway | 13 | 5.99E-04 |
| GO:0034097~response to cytokine | 45 | 0.001367 |
| GO:0016070~RNA metabolic process | 161 | 0.004935 |
| GO:0046395~carboxylic acid catabolic process | 18 | 0.005979 |
| GO:0006952~defense response | 67 | 5.93E-04 |
| GO:0055088~lipid homeostasis | 14 | 0.007424 |
| GO:0010628~positive regulation of gene expression | 71 | 0.012472 |
| GO terms overrepresented among DEGs with lower expression in the LRFI group vs HRFI group | ||
| GO:0007166~cell surface receptor signalling pathway | 120 | 1.86E-06 |
| GO:0030198~extracellular matrix organisation | 32 | 1.91E-06 |
| GO:0043062~extracellular structure organisation | 32 | 1.37E-06 |
| GO:0022610~biological adhesion | 85 | 4.48E-06 |
| GO:0007155~cell adhesion | 84 | 6.60E-06 |
| GO:2000026~regulation of multicellular organismal development | 78 | 6.00E-04 |